Home >> Signaling Pathways >> Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Products for  Apoptosis

  1. Cat.No. 产品名称 Information
  2. GC47787 Nocardamine

    Desferrioxamine E, Proferrioxamine E

    A ferrioxamine siderophore
  3. GC47771 NG 25 (hydrochloride hydrate) An inhibitor of MAP4K2 and TAK1
  4. GC47760 Nebularine

    9-(Β-D-呋喃核糖)嘌呤

    A purine ribonucleoside with diverse biological activities
  5. GC47728 N,O-Diacetyltyramine

    4-(2-acetamidoethyl) Phenyl Acetate

    A fungal metabolite with diverse biological activities
  6. GC47716 Myxochelin A

    (S)-Myxochelin A

    A microbial metabolite with diverse biological activities
  7. GC47711 Myceliothermophin E A fungal metabolite with anticancer and antimicrobial activities
  8. GC47620 Mensacarcin A bacterial metabolite with anticancer activity
  9. GC47607 Mca-YVADAP-K(Dnp)-OH (trifluoroacetate salt)

    Caspase-1 Fluorogenic Substrate V, Mca-Tyr-Val-Ala-Asp-Ala-Pro-Lys(DNP)-OH, Mca-YVADAP-Lys(Dnp)-OH, (7-Methoxycoumarin-4-yl)acetyl-YVADAPK(2,4-dinitrophenyl)-OH

    A neuropeptide with diverse biological activities
  10. GC47582 Lupulone

    蛇床酮

    A beta-acid
  11. GC47571 Lithocholic Acid-d4

    石胆酸-2,2,4,4-D4,3α-Hydroxy-5β-cholanic acid-d4

    An internal standard for the quantification of lithocholic acid
  12. GC47553 Lenalidomide-d5

    来那度胺-D5,CC-5013-d5

    An internal standard for the quantification of lenalidomide
  13. GC47544 Lauric Acid-13C

    十二(烷)酸

    An internal standard for the quantification of lauric acid
  14. GC47470 Isovaleryl-L-carnitine-d3 (chloride)

    CAR 5:0-d3, C5:0 Carnitine-d3, L-Carnitine isovaleryl ester-d3, L-Isovalerylcarnitine-d3

    A neuropeptide with diverse biological activities
  15. GC47409 Glycocholic Acid-d4

    甘氨胆酸-D4

    An internal standard for the quantification of glycocholic acid
  16. GC47408 Glycochenodeoxycholic Acid-d4

    甘氨鹅脱氧胆酸-D4,Chenodeoxycholylglycine-d4

    An internal standard for the quantification of glycochenodeoxycholic acid
  17. GC47407 Glycochenodeoxycholic Acid (sodium salt hydrate)

    GCDCA, NSC 681056

    A neuropeptide with diverse biological activities
  18. GC47399 Geranylgeranoic Acid

    GGA

    An isoprenoid with anticancer activity

  19. GC47398 Genistein-d4

    金雀异黄酮-D4,NPI 031L-d4

    An internal standard for the quantification of genistein
  20. GC47396 Gemcitabine monophosphate

    吉西他滨单磷酸酯,Gemcitabine 5′-phosphate

    A derivative of gemcitabine
  21. GC47393 Ganglioside GM1 Mixture (porcine brain) (ammonium salt)

    GM1, Monosialoganglioside GM1

    A sphingolipid
  22. GC47392 Ganglioside GM1 Mixture (ovine) (ammonium salt)

    GM1, Monosialoganglioside GM1

    A sphingolipid
  23. GC47279 Echinosporin

    (-)-棘孢链菌素

    A bacterial metabolite with antibacterial and anticancer activities
  24. GC47187 Deoxycholic Acid-d4

    去氧胆酸 d4

    An internal standard for the quantification of deoxycholic acid
  25. GC47167 Dacarbazine-d6

    达卡巴嗪-D6,Imidazole Carboxamide-d6

    An internal standard for the quantification of dacarbazine
  26. GC47166 Dabrafenib-d9

    达帕菲尼杂质,GSK2118436A-d9; GSK2118436-d9

    An internal standard for the quantification of dabrafenib
  27. GC47148 Cyclophosphamide-d4

    环磷酰胺 d4

    An internal standard for the quantification of cyclophosphamide
  28. GC47105 Clonostachydiol A fungal metabolite with anticancer and anthelmintic activities
  29. GC47098 CL2-SN-38 (dichloroacetic acid salt) An antibody-drug conjugate containing SN-38
  30. GC47073 Ceramides (hydroxy) A mixture of hydroxy fatty acid-containing ceramides
  31. GC47070 Celecoxib-d7

    塞来昔布-D7,SC 58635-d7

    An internal standard for the quantification of celecoxib
  32. GC47065 CAY10773 A derivative of sorafenib
  33. GC47061 CAY10763 A dual inhibitor of IDO1 and STAT3 activation
  34. GC47057 CAY10755 A fungal metabolite with anticancer activity
  35. GC47055 CAY10749 A dual inhibitor of PARP and PI3K
  36. GC47053 CAY10746 A ROCK1 and ROCK2 inhibitor
  37. GC47051 CAY10740 (hydrochloride) A neuropeptide with diverse biological activities
  38. GC47042 Carfilzomib-d8

    来那度胺-D8

    An internal standard for the quantification of carfilzomib
  39. GC47016 Cabergoline-d6

    FCE-21336-d6

    A neuropeptide with diverse biological activities
  40. GC46989 C18 dihydro Ceramide-d3 (d18:0/18:0-d3)

    N-octadecanoyl-D-erythro-Dihydrosphingosine-d3

    An internal standard for the quantification of C18 dihydro ceramide
  41. GC46976 C16 Ceramide-d7 (d18:1-d7/16:0)

    Palmitoyl Ceramide-d7

    An internal standard for the quantification of C16 ceramide
  42. GC46962 Busulfan-d8

    白消安 d8

    An internal standard for the quantification of busulfan
  43. GC46942 Bortezomib-d15

    LDP-341-d15, MG-341-d15, PS-341-d15

    A neuropeptide with diverse biological activities
  44. GC46914 Bendamustine-d4 (hydrochloride)

    盐酸苯达莫司汀 d4 (盐酸盐)

    A neuropeptide with diverse biological activities
  45. GC46904 Azoxystrobin

    嘧菌酯

    A broad-spectrum fungicide
  46. GC46901 Azadirachtin

    印楝素

    A naturally-occurring insecticide
  47. GC46895 Aurintricarboxylic Acid (ammonium salt)

    铝试剂

    A protein synthesis inhibitor with diverse biological activities
  48. GC46892 ATRA-BA Hybrid A prodrug form of all-trans retinoic acid and butyric acid
  49. GC46882 Artemisinin-d3

    Qinghaosu-d3; NSC 369397-d3

    An internal standard for the quantification of artemisinin
  50. GC46878 Aranciamycin

    阿雷西霉素

    A fungal metabolite with diverse biological activities
  51. GC46862 Apigenin-d5

    3,6,8,3’,5’-d5-Apigenin, Chamomile-d5, Flavone-d5, Versulin-d5

    An internal standard for the quantification of apigenin

Items 901 to 950 of 2733 total

per page

Set Descending Direction